clinical trial · NCT07004972
A Study of Mavacamten in Adults With Obstructive Hypertrophic Cardiomyopathy in India (ROVER)
Bristol-Myers Squibb·phase4·recruiting·n = 50
Symptomatic Obstructive Hypertrophic CardiomyopathyMavacamten
brief summary
The purpose of this study is to evaluate the safety, tolerability and effectiveness of mavacamten in adults with obstructive hypertrophic cardiomyopathy in India.
started
Sep 4, 2025
primary completion
Dec 13, 2027
completion
Dec 13, 2027
last updated
Mar 4, 2026
official title
A Phase 4, Single-Arm, Open-Label Study to Evaluate Safety, Tolerability, and Efficacy of Mavacamten in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy in India
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol